[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100314295":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":27,"centralContacts":51,"locations":60,"responsibleParty":80,"collaborators":27,"id":82,"slug":83,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":86,"acronym":87,"eligibilityCriteria":88,"healthyVolunteers":89,"sex":90,"minAge":91,"maxAge":27,"enrollmentInfo":92,"targetDuration":27,"studyType":95,"phases":96,"briefSummary":98,"conditions":99,"keywords":101,"overallStatus":63,"whyStopped":27,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"University Hospital, Rouen","OTHER",[8,19],{"label":9,"type":6,"description":10,"interventionNames":11},"Alcoholic exposure group","Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire",[12,13,14,15,16,17,18],"Behavioral: ASQ parental questionnaire","Behavioral: Development scales","Behavioral: Scale of Conners","Behavioral: SCQ Questionnaire","Procedure: Blood sample (mother)","Procedure: Cord blood sample","Procedure: Placenta sample",{"label":20,"type":6,"description":10,"interventionNames":21},"Control",[12,13,14,15,16,17,18],[23,28,32,35,39,44,48],{"type":24,"name":25,"description":25,"armGroupLabels":26,"otherNames":27},"BEHAVIORAL","ASQ parental questionnaire",[9,20],null,{"type":24,"name":29,"description":30,"armGroupLabels":31,"otherNames":27},"Development scales","WPPSI - IV and NEPSY development scales",[9,20],{"type":24,"name":33,"description":33,"armGroupLabels":34,"otherNames":27},"Scale of Conners",[9,20],{"type":24,"name":36,"description":37,"armGroupLabels":38,"otherNames":27},"SCQ Questionnaire","SCQ questionnaire",[9,20],{"type":40,"name":41,"description":42,"armGroupLabels":43,"otherNames":27},"PROCEDURE","Blood sample (mother)","Blood sample (mother) before delivery",[9,20],{"type":40,"name":45,"description":46,"armGroupLabels":47,"otherNames":27},"Cord blood sample","Cord blood sample after delivery",[9,20],{"type":40,"name":49,"description":49,"armGroupLabels":50,"otherNames":27},"Placenta sample",[9,20],[52,57],{"name":53,"role":54,"phone":55,"phoneExt":27,"email":56},"POURCHER","CONTACT","02 32 88 82 65","cecile.pourcher@chu-rouen.fr",{"name":58,"role":54,"phone":55,"phoneExt":27,"email":59},"BLOT","julien.blot@chu-rouen.fr",[61],{"facility":62,"status":63,"city":64,"state":27,"zip":65,"country":66,"countryCode":67,"cosmosGeoPoint":68,"geoPoint":73,"contacts":74},"UH ROUEN","RECRUITING","Rouen","76000","France","FR",{"type":69,"coordinates":70},"Point",[71,72],1.09932,49.44313,{"lat":72,"lon":71},[75,76,77],{"name":53,"role":54,"phone":55,"phoneExt":27,"email":56},{"name":58,"role":54,"phone":55,"phoneExt":27,"email":59},{"name":78,"role":79,"phone":27,"phoneExt":27,"email":27},"MARRET","PRINCIPAL_INVESTIGATOR",{"type":81,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100314295","in-utero-alcoholic-exposure-plgf-biomarker-of-fetal-brain-lesions-100314295",false,"NCT03371641","In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions","ALCOBRAIN","Inclusion Criteria:\n\nMother:\n\n* Pregnant woman (monofetal or twin pregnancy, whatever the parity)\n* Age\\> or = to 18 years\n* Person affiliated to a social security system\n* Person who read and understood the information form and signed the consent form\n\n  * Alcohol exposure group Chronic consumption of at least 30 g of alcohol per week or acute consumption of \"binge drinking\" type during pregnancy (knowing that a unit of 10 g of pure alcohol corresponds to 25 cl of beer 4 ° 5, 10 cl of wine at 12 °, 3 cl of whiskey, 7 cl of Porto ...)\n  * Control group No alcohol consumption during pregnancy\n  * Child Informed parents and written consent signed by the father and mother for the child's participation in this research (unless one of the parents does not have parental authority)\n\nExclusion Criteria:\n\n* Female under 18\n* Pregnant woman with clinical suspicion of pre-eclampsia and \u002F or HELLP syndrome\n* Person deprived of liberty by an administrative or judicial decision or protected major subject (under tutorship or curatorship)\n* Patient participating in another interventional trial or who participated in another interventional trial during pregnancy",true,"FEMALE","18 Years",{"count":93,"type":94},60,"ESTIMATED","INTERVENTIONAL",[97],"NA","This study aims to validate that PLGF is a biomarker of cerebral lesions and therefore of secondary developmental disorders and disabilities that will be best diagnosed at 2 and 6 years of age.",[100],"Fetal Alcohol Syndrome",[100,102,103,104,105,106],"Pregnancy","Biomarker","PlGF","Cognitive development","Behavior troubles","2026-02-04",{"date":109,"type":110},"2026-02-06","ACTUAL",{"date":112,"type":110},"2017-01-27",{"date":114,"type":94},"2026-03-27",{"name":5,"class":6},1]